Mostrando 2 resultados de: 2
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
ArticleAbstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a poPalabras claves:Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markersAutores:Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopusEag1 potassium channels as markers of cervical dysplasia
ArticleAbstract: Human ether à-go-go 1 (Eag1) potassium channels are potential tumor markers and therapeutic targetsPalabras claves:Cervical Cancer, estrogens, Human ether à-go-go 1, Potassium channels, tumor markersAutores:Aguilar-Guadarrama R., Gamboa-Dominguez A., Garcia-Villa E., Gariglio P., Hernández-gallegos E., Hinojosa L.M., Javier Camacho, Martínez-Benítez B., Montante-Montes D., Ortiz C.S., Pardo L.A., Ramírez A., Saqui-Salces M., Solís-Pancoatl M., Stühmer W.Fuentes:scopus